These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 62915)

  • 1. Cerebral atrophy and cognitive impairment in chronic schizophrenia.
    Marsden CD
    Lancet; 1976 Nov; 2(7994):1079. PubMed ID: 62915
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine and schizophrenia.
    Meltzer HY; Goode DJ; Fang VS; Schyve P; Young M
    Lancet; 1976 Nov; 2(7995):1142. PubMed ID: 62982
    [No Abstract]   [Full Text] [Related]  

  • 3. [Late dyskenetic neuroleptic syndrome (persistent dyskinesia). Apropos of 2 cases].
    Rendueles Olmedo G
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976; 4(6):371-6. PubMed ID: 1030180
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacotherapy of schizophrenia.
    Ban TA
    Curr Psychiatr Ther; 1976; 16():163-75. PubMed ID: 991627
    [No Abstract]   [Full Text] [Related]  

  • 5. Eye blink and schizophrenia: psychosis or tardive dyskinesia?
    Stevens JR
    Am J Psychiatry; 1978 Feb; 135(2):223-6. PubMed ID: 623338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenics and tranquilizers.
    Hoffer A
    Can Med Assoc J; 1982 Jun; 126(12):1375-6. PubMed ID: 7083093
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychopharmacology for psychiatric and psychiatric-organic diseases.
    Abrams RS
    Compr Ther; 1978 May; 4(5):26-32. PubMed ID: 657771
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinicl experience with flupenthixol in the treatment of chronic schizophrenia.
    Molcan J; Kukucová H; Koníková M
    Act Nerv Super (Praha); 1971; 13(3):180-1. PubMed ID: 5113828
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes in chronic schizophrenia.
    Marinow A
    Dis Nerv Syst; 1971 Nov; 32(11):777-8. PubMed ID: 5131772
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic-induced akathisia and dystonia triggered by alcohol.
    Lutz EG
    JAMA; 1976 Nov; 236(21):2422-3. PubMed ID: 989862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 12. Epilepsy control, neuroleptics, and mental state.
    Siris JH; Werner WL
    JAMA; 1978 Jan; 239(5):402-3. PubMed ID: 621833
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clozapine in long-term therapy of chronic schizophrenia].
    Gross H; Langner E; Pfolz H
    Arzneimittelforschung; 1974 Jul; 24(7):987-9. PubMed ID: 4408041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Psychoactive drugs in geriatric practice. The danger of inducing bluntness and confusion].
    Naess K
    Tidsskr Nor Laegeforen; 1973 May; 93(13):943-5. PubMed ID: 4751593
    [No Abstract]   [Full Text] [Related]  

  • 15. Pimozide as maintenance treatment in chronic schizophrenia.
    Br J Clin Pract; 1971 Sep; 25(9):417-20. PubMed ID: 4939599
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebral atrophy and cognitive impairment in chronic schizophrenia.
    Hill D
    Lancet; 1976 Nov; 2(7995):1132. PubMed ID: 62962
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of butaperazine in chronic schizophrenia.
    Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR
    Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043
    [No Abstract]   [Full Text] [Related]  

  • 18. [Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].
    Kaiser W
    Nervenarzt; 1989 Apr; 60(4):206-12. PubMed ID: 2566936
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R; Gagnon MA; Gauthier R; Jéquier JC
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE; Coyne L
    Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.